APA (7th ed.) Citation

Sakamoto, K., Matsuki, S., Irie, S., Uchida, N., Hayashi, N., Horiuchi, M., & Ren, S. (2020). A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men. Clinical Pharmacology in Drug Development, 9(7), 833. https://doi.org/10.1002/cpdd.775

Chicago Style (17th ed.) Citation

Sakamoto, Kei, Shunji Matsuki, Shin Irie, Naoki Uchida, Nobuya Hayashi, Masato Horiuchi, and Song Ren. "A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men." Clinical Pharmacology in Drug Development 9, no. 7 (2020): 833. https://doi.org/10.1002/cpdd.775.

MLA (9th ed.) Citation

Sakamoto, Kei, et al. "A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men." Clinical Pharmacology in Drug Development, vol. 9, no. 7, 2020, p. 833, https://doi.org/10.1002/cpdd.775.